FDA — authorised 23 April 2014
- Application: ANDA201273
- Marketing authorisation holder: SUN PHARM
- Indication: Labeling
- Status: approved
FDA authorised Nicotinic Acid on 23 April 2014 · 6,858 US adverse-event reports
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 23 April 2014; FDA authorised it on 23 April 2014; FDA authorised it on 11 December 2015.
SUN PHARM holds the US marketing authorisation.